South Korea · Delayed Price · Currency is KRW Genesem Statistics
Total Valuation
Genesem has a market cap or net worth of KRW 77.78 billion. The enterprise value is 85.65 billion.
| Market Cap | 77.78B |
| Enterprise Value | 85.65B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Genesem has 8.77 million shares outstanding.
| Current Share Class | 8.77M |
| Shares Outstanding | 8.77M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 44.68% |
| Owned by Institutions (%) | 0.00% |
| Float | 4.85M |
Valuation Ratios
The trailing PE ratio is 44.73 and the forward PE ratio is 13.60.
| PE Ratio | 44.73 |
| Forward PE | 13.60 |
| PS Ratio | 1.37 |
| PB Ratio | 1.58 |
| P/TBV Ratio | 1.64 |
| P/FCF Ratio | 39.90 |
| P/OCF Ratio | 18.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.63, with an EV/FCF ratio of 43.93.
| EV / Earnings | 49.26 |
| EV / Sales | 1.51 |
| EV / EBITDA | 21.63 |
| EV / EBIT | 31.54 |
| EV / FCF | 43.93 |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.39.
| Current Ratio | 1.35 |
| Quick Ratio | 0.76 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | 4.92 |
| Debt / FCF | 9.98 |
| Interest Coverage | 3.33 |
Financial Efficiency
Return on equity (ROE) is 3.68% and return on invested capital (ROIC) is 2.48%.
| Return on Equity (ROE) | 3.68% |
| Return on Assets (ROA) | 1.95% |
| Return on Invested Capital (ROIC) | 2.48% |
| Return on Capital Employed (ROCE) | 4.88% |
| Revenue Per Employee | 361.12M |
| Profits Per Employee | 11.08M |
| Employee Count | 157 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 2.02 |
Taxes
In the past 12 months, Genesem has paid 152.26 million in taxes.
| Income Tax | 152.26M |
| Effective Tax Rate | 7.92% |
Stock Price Statistics
The stock price has increased by +20.33% in the last 52 weeks. The beta is 1.21, so Genesem's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | +20.33% |
| 50-Day Moving Average | 8,369.80 |
| 200-Day Moving Average | 7,676.00 |
| Relative Strength Index (RSI) | 47.72 |
| Average Volume (20 Days) | 79,092 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genesem had revenue of KRW 56.70 billion and earned 1.74 billion in profits. Earnings per share was 198.29.
| Revenue | 56.70B |
| Gross Profit | 21.74B |
| Operating Income | 2.72B |
| Pretax Income | 1.92B |
| Net Income | 1.74B |
| EBITDA | 3.96B |
| EBIT | 2.72B |
| Earnings Per Share (EPS) | 198.29 |
Balance Sheet
The company has 11.47 billion in cash and 19.46 billion in debt, giving a net cash position of -7.99 billion or -911.34 per share.
| Cash & Cash Equivalents | 11.47B |
| Total Debt | 19.46B |
| Net Cash | -7.99B |
| Net Cash Per Share | -911.34 |
| Equity (Book Value) | 49.29B |
| Book Value Per Share | 5,634.80 |
| Working Capital | 10.71B |
Cash Flow
In the last 12 months, operating cash flow was 4.26 billion and capital expenditures -2.31 billion, giving a free cash flow of 1.95 billion.
| Operating Cash Flow | 4.26B |
| Capital Expenditures | -2.31B |
| Free Cash Flow | 1.95B |
| FCF Per Share | 222.32 |
Margins
Gross margin is 38.34%, with operating and profit margins of 4.79% and 3.07%.
| Gross Margin | 38.34% |
| Operating Margin | 4.79% |
| Pretax Margin | 3.39% |
| Profit Margin | 3.07% |
| EBITDA Margin | 6.98% |
| EBIT Margin | 4.79% |
| FCF Margin | 3.44% |
Dividends & Yields
This stock pays an annual dividend of 75.00, which amounts to a dividend yield of 0.85%.
| Dividend Per Share | 75.00 |
| Dividend Yield | 0.85% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 37.82% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.83% |
| Earnings Yield | 2.24% |
| FCF Yield | 2.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 10, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Nov 10, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Genesem has an Altman Z-Score of 2.4 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.4 |
| Piotroski F-Score | 5 |